|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Common stock issued for services | |||||
| Provision on credit losses | |||||
| Change in fair value of contingent consideration liabilities | |||||
| Impairment of goodwill | |||||
| Stock-based compensation | |||||
| Stock Compensation expense for non-employees | |||||
| Disposal of property and equipment | |||||
| Amortization of operating lease right of use asset | |||||
| Abandoned patent costs | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Inventory | |||||
| Deposits | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Operating lease liability | |||||
| Sales tax payable | |||||
| Deferred revenue | |||||
| Deferred tax liabilities | |||||
| Other long term liabilities | |||||
| Net cash used in operating activities | |||||
| Investing Activities: | |||||
| Acquisitions, net of cash acquired | |||||
| Working capital payment for acquisition | |||||
| Purchase of property and equipment | |||||
| Payment of Deferred Consideration | |||||
| Funding of patent costs | |||||
| Net cash used in investing activities | |||||
| Financing Activities: | |||||
| Proceeds from sale of common stock | |||||
| At the Market Issuance | |||||
| Public Offering | |||||
| Total proceeds from sale of common stock | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Proceeds from warrant exercises | |||||
| Borrowings of note payable | |||||
| Payments of equity offering costs | |||||
| Proceeds from issuance of common stock, pursuant to public offering | |||||
| Net cash provided by financing activities | |||||
| Net (decrease) increase in cash | |||||
| Cash at beginning of period | |||||
| Cash at end of period | |||||
| Effect of exchange rate changes | |||||
| Supplemental Disclosure of Cash Flow Information: | |||||
| Cash paid for interest | |||||
| Cash paid for taxes | |||||
| Fair value of common stock issued as consideration for business combination | |||||
| Purchase of property and equipment by incurring current liabilities | |||||
| Right-of-use assets obtained in exchange for lease liabilities | |||||
| Issuance of stock for Committed Equity Line | |||||
| Warrants issued for services to non-employee | |||||
| Shares issued for services to non-employee | |||||
| Supplemental Disclosure of Non-Cash Investing and Financing Activities: | |||||
| Right-of-use assets obtained in exchange for lease liabilities | |||||
| Settlement of earnout related to acquisition | |||||
| Fair value of common stock issued as consideration for business combination | |||||
| Purchase of property and equipment by incurring current liabilities | |||||
Loading...